D-63
Today is  2026. 07. 09.
D-63
Today is  2026. 07. 09.

Scientific Program

Program Scientific Program
Program At a Glance Scientific Program Invited Speakers

  • Day 1 (Thu, Sep 10)
    Room A
    10:00-11:20 KOR

    Heart Failure Masterclass: The Day 1 Essentials [심부전 진단과 치료 처음부터 시작하기]

    Seongwoo Han (Hallym Univ., Korea)
    Jin Oh Choi (Sungkyunkwan Univ., Korea)

    심부전 진단과 치료를 기초부터 다시 공부해 본다.
    완전히 이해하고 있다고 생각하지만 의외로 놓치고 있는 경우가 종종 있다. 이 세션을 통해서 심부전 입문자와 전문가 모두 기초를 다시 공고히 다질 수 있도록 하고자 한다.
    10:00-10:15 HF Classification: From Ejection Fraction to Phenotypes [심부전 분류 제대로 이해하기] Jin Joo Park (Seoul National Univ., Korea)
    10:15-10:30 Biomarker Interpretation: Pitfalls to Clinical Practice [심부전 바이오마커 해석의 함정과 실제 임상적용] Hyung Yoon Kim (Incheon Sejong Hospital, Korea)
    10:30-10:45 Guideline-Directed Medical Treatment for HFrEF [박출률 감소 심부전 약물치료 이것만은 알자] Kyeong-Hyeon Chun (Yonsei Univ., Korea)
    10:45-11:00 Guideline-Directed Medical Treatment for HFpEF [박출률 보존 심부전 약물치료 이것만은 알자] Jung-Woo Son (Yonsei Wonju Univ., Korea)
    11:00-11:20 Discussion Eui-Soon Kim (The Catholic Univ. of Korea, Korea)
    Jiwon Kim (Sungkyunkwan Univ., Korea)
    Minjung Park (Seoul National Univ., Korea)
    Heekyung Seo (Yonsei Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room A
    12:10-13:10 KOR

    Luncheon Session 1 Luncheon Session 1 logo

    will be updated.
  • Day 1 (Thu, Sep 10)
    Room A
    13:10-14:30 KOR

    Joint Session with KTCVS

    Minimizing Risk in HF Patients: Modern Surgical and Transcatheter Solutions

    Mi Seung Shin (Gachon Univ., Korea)
    TBD

    고위험 심부전 환자에서 수술적 및 경피적 중재술의 위험도를 평가하고 최적의 치료 전략을 선택하는 능력을 함양한다.
    고위험 심부전 환자에서 수술적 교정과 경피적 중재술의 선택은 심장외과와 심부전 전문의 간의 긴밀한 협력을 필요로 한다. 본 세션은 frailty 평가, 판막 재치환, 최소침습 수술 등 실제 임상에서 마주치는 고위험 상황의 최적 전략을 함께 논의하고자 한다.
    13:10-13:25 Beyond Numerical Scores: Integrating Frailty into Surgical vs. Transcatheter Decision-Making Sung Ji Park (Sungkyunkwan Univ., Korea)
    13:25-13:40 Transcatheter Valve-in-Valve Procedure for Deteriorated Bioprostheses Cheol Woong Yu (Korea Univ., Korea)
    13:40-13:55 Optimizing SAVR: Rapid Deployment and Sutureless Valves in the TAVR Era Jae-Sung Choi (Seoul National Univ., Korea)
    13:55-14:10 Tailoring Surgical Options for High-Risk HF Patients: The Role of Minimally Invasive Technique Min Ho Ju (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea)
    14:10-14:30 Discussion Yoon Seok Kim (Keimyung Univ., Korea)
    Sook Jin Lee (Hallym Univ., Korea)
    Seong-Hoon Lim (Dankook Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room A
    14:50-16:10 KOR

    Cardio-Obstetric Challenges: Managing HF and Cardiomyopathy in Pregnancy

    Myung-A Kim (Jeju National Univ., Korea)
    Soo Young Oh (Sungkyunkwan Univ., Obstetrics and Gynecology, Korea)

    임신 중 심부전 및 심근병증의 위험 인자를 평가하고 다학제적 접근법을 통한 관리 전략을 이해한다.
    심부전이나 심근병증을 동반한 여성에게 임신과 출산은 생명을 위협하는 고위험 상황이 될 수 있으며, 주산기 심근병증의 재발 위험과 보조생식술의 심혈관 영향은 아직 충분히 규명되지 않은 영역이다. 본 세션은 산부인과와의 다학제적 협력을 바탕으로 임신 관련 심부전의 위험 층화, 실제 관리 전략 및 장기 예후를 다루고자 한다.
    14:50-15:05 Pregnancy and Heart Failure: Risk Stratification and Multidisciplinary Care Kina Jeon (The Catholic Univ. of Korea, Korea)
    15:05-15:20 Assisted Reproduction: Hormones, Heart Failure, and Thrombosis TBD
    15:20-15:35 Practical Management of Peripartum Cardiomyopathy Sunki Lee (Korea Univ., Korea)
    15:35-15:50 Strategies for Subsequent Pregnancy and Long-Term Outcomes of Peripartum Cardiomyopathy Minjung Park (Seoul National Univ., Korea)
    15:50-16:10 Discussion Hayan Kwon (Yonsei Univ., Obstetrics and Gynecology, Korea)
    Mi Jeong Kim (The Catholic Univ., Korea)
    Sang Min Park (Eulji Univ., Korea)
    Jihee Son (Chung-Ang Univ., Korea)
    Jungwon Lee (Yonsei Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room A
    16:10-17:40 KOR

    Joint Session with KCSWG

    HF and Cardiogenic Shock: From Decompensation to Advanced Support

    Hyun-Jai Cho (Seoul National Univ., Korea)
    Jeong Hoon Yang (Sungkyunkwan Univ., Korea)

    심인성 쇼크에서 기계적 순환 보조 장치의 종류와 적용 시점을 이해하고 다학제적 팀 접근법을 통한 결과 최적화 전략을 습득한다.
    심인성 쇼크에서 MCS 장치의 선택과 적용 시점, bridge-to-bridge 전략, weaning 시점의 판단은 아직 표준화되지 않은 부분이 많다. 본 세션은 임펠라 국내 초기 경험을 포함한 최신 MCS 실전 적용 사례와 다학제 팀 운영 전략을 공유하고자 한다.
    16:10-16:28 Critical Decision Making: Choosing the Right MCS in Cardiogenic Shock Min-Seok Kim (Ulsan Univ., Korea)
    16:28-16:46 Early Clinical Experience of Impella in Korea: Challenges and Success Jeong Hoon Yang (Sungkyunkwan Univ., Korea)
    16:46-17:04 Bridge-to-Bridge Strategy: Transition from Temporary MCS to Durable LVAD Yang Hyun Cho (Sungkyunkwan Univ., Korea)
    17:04-17:22 Optimizing Outcomes: Multidisciplinary Team Approach in MCS Management Soo Yong Lee (Pusan National Univ., Korea)
    17:22-17:40 Discussion Jeehoon Kang (Seoul National Univ., Korea)
    Jihoon Kim (Hallym Univ., Thoracic and Cardiovascular Surgery, Korea)
    Heayoung Shin (Sungkyunkwan Univ., Korea)
    Jae Seung Jung (Korea Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room B
    10:00-11:20 ENG

    HF Therapy in Transition: From Guideline to Precision Medicine

    Seok Min Kang (Yonsei Univ., Korea)
    TBD

    To review the evolving landscape of heart failure therapy, from evidence-based guideline implementation to precision medicine approaches integrating genomics and multi-omics.
    Heart failure management is entering a new era where traditional guideline-based care is complemented by precision medicine. As genomic, phenotypic, and multi-omics data reshape our understanding of disease heterogeneity, this session explores how global and Korean guidelines are evolving to move beyond a “one-size-fits-all” approach.
    10:00-10:15 How Guidelines Shape HF Care? Unique Insights from Japan Takeshi Kitai (National Cerebral and Cardiovascular Center, Japan)
    10:15-10:30 What’s New in 2026? A Deep Dive into the ESC HF Guidelines Wilfried Mullens (Ziekenhuis Oost Limburg, Genk and Univ. Hasselt, Belgium)
    10:30-10:45 Where is the KSHF Guideline Heading? Integrating Korean Evidence for the Future TBD
    10:45-11:00 Revisiting the Effects of Novel HF Therapies Through Genomic and Multi-Omics Analyses Yasuhiko Sakata (National Cerebral and Cardiovascular Center, Japan)
    11:00-11:20 Discussion Kyung-Jin Kim (Ewha Womans Univ., Korea)
    Sung-Hee Shin (Inha Univ., Korea)
    Chan Joo Lee (Yonsei Univ., Korea)
    Seokjae Hwang (Gumdan Top General Hospiital, Korea)
  • Day 1 (Thu, Sep 10)
    Room B
    12:10-13:10 ENG

    Luncheon Session 2 Luncheon Session 2 logo

    will be updated.
  • Day 1 (Thu, Sep 10)
    Room B
    13:10-14:30 ENG

    Current Landscape and Future Pathways of Transcatheter HF Management

    Jae-Joong Kim (Ulsan Univ., Korea)
    Koichiro Kinugawa (Univ. of Toyama, Japan)

    To understand current transcatheter treatment strategies for heart failure and explore emerging device-based interventions for structural and functional cardiac disease.
    Transcatheter therapies are rapidly expanding treatment options for heart failure patients with complex structural and valvular diseases. This session highlights contemporary evidence, optimal patient selection, and procedural concepts for novel device therapies—such as interatrial shunting and transcatheter tricuspid interventions.
    13:10-13:30 Interatrial Shunting in HF: Contemporary Evidence and Ongoing Challenges Liviu Klein (Univ. of California San Francisco, USA)
    13:30-13:50 T-TEER in Functional TR Management: Patient Selection and Outcomes Takeshi Kitai (National Cerebral and Cardiovascular Center, Japan)
    13:50-14:10 SPACER Pivot in Functional TR management: Concept to Clinical Practice Geu Ru Hong (Yonsei Univ., Korea)
    14:10-14:30 Discussion Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
    Jang Won Son (Yeungnam Univ., Korea)
    Yuhui Zhang (Fuwai Hospital, Chinese Academy of Medical Sciences, China)
  • Day 1 (Thu, Sep 10)
    Room B
    14:50-16:10 ENG

    Joint Session with HFSA

    Emerging Evidence and Changing Treatment Paradigms in Cardiomyopathy

    Byung Su Yoo (Yonsei Wonju Univ., Korea)
    Kenneth Margulies (Univ. of Pennsylvania, USA)

    To provide an updated understanding of contemporary treatment strategies and emerging evidence in cardiomyopathies, including ATTR amyloidosis and hypertrophic cardiomyopathy.
    In collaboration with the HFSA, this session reviews the rapidly evolving landscape of cardiomyopathy care driven by disease-specific and precision-based therapies. Experts will dissect contemporary evidence, real-world practices, and unresolved questions regarding targeted treatments for ATTR-CM and non-obstructive HCM using novel cardiac myosin inhibitors.
    14:50-15:10 ATTR-CM in the United States: Evidence to Practice Omar Siddiqi (Boston Univ. School of Medicine, USA)
    15:10-15:30 Management of Obstructive HCM: Contemporary Treatment and Long-Term Outcomes Sung-Hee Shin (Inha Univ., Korea)
    15:30-15:50 Management of Non-obstructive HCM: Who Benefits from Cardiac Myosin Inhibitor? Kenneth Margulies (Univ. of Pennsylvania, USA)
    15:50-16:10 Discussion Darae Kim (Sungkyunkwan Univ., Korea)
    Jung Hyun Choi (Pusan National Univ., Korea)
    Matthew Martinez (Mayo Clinic, USA)
  • Day 1 (Thu, Sep 10)
    Room B
    16:10-17:40 ENG

    Joint Session with CHFA

    Global Lessons of Asian Heart Failure

    Myeong-Chan Cho (Chungbuk National Univ., Korea)
    Jian Zhang (Fuwai hospital, China)

    To explore the unique clinical characteristics and management challenges of heart failure in Asian populations.
    Heart failure in Asia demonstrates distinctive phenotypes, such as lean HFpEF, unique hypertensive heart disease profiles, and specific CKM syndrome patterns. Jointly organized with the CHFA, this session highlights crucial regional perspectives, therapeutic dosing challenges, and shared experiences in mechanical circulatory support across Asian countries.
    16:10-16:28 Lean HFpEF, Hypertensive Heart Disease, and Small Ventricle in Asia Jung Hyun Choi (Pusan National Univ., Korea)
    16:28-16:46 Quadruple Therapy in Asian Patients: Efficacy, Tolerability, and Dosing Issues Yuhui Zhang (Fuwai Hospital, Chinese Academy of Medical Sciences, China)
    16:46-17:04 CKM Syndrome and Heart Failure: An Asian Epidemic Jung-Woo Son (Yonsei Wonju Univ., Korea)
    17:04-17:22 Mechanical Circulatory Support in Asian Patients with Heart Failure Xiaowei Zhang (Lanzhou Univ. Second Hospital, China)
    17:22-17:40 Discussion Minkwan Kim (Yonsei Univ., Korea)
    Bo Eun Park (Kyungpook National Univ., Korea)
    Sukmin Seo (The Catholic Univ., Korea)
    Kangun Choi (Yeungnam Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room C
    10:00-11:20 ENG

    Everything about the Atrium in Heart Failure

    Daegyun Park (Hallym Univ., Korea)
    Sung Kee Ryu (Ewha Womans Univ., Korea)

    심부전에서 심방의 구조적·기능적 변화와 임상적 의미를 이해한다.
    심부전 진료에서 심방은 증상 발생과 예후를 결정하는 중요한 요소이다. 이 세션에서는 심방 리모델링, 심방-심실 상호작용, 침습적 혈역학 평가를 통해 심부전 환자의 병태생리를 보다 입체적으로 이해하고자 한다.
    10:00-10:15 Atrial Myopathy: The Missing Link in HFpEF Development Dong-Hyuk Cho (Korea Univ., Korea)
    10:15-10:30 Atrial Functional Changes According to Cardiac Rhythm Mi-Hyang Jung (The Catholic Univ. of Korea, Korea)
    10:30-10:45 Atrio-Ventricular Coupling and Hemodynamic Consequences Kyu-Yong Ko (Yonsei Univ., Korea)
    10:45-11:00 Invasive Hemodynamics and LA Pressure Jihoon Kim (Sungkyunkwan Univ., Korea)
    11:00-11:20 Discussion Dae Young Kim (Inha Univ., Korea)
    Mi Jeong Kim (The Catholic Univ., Korea)
    TBD
  • Day 1 (Thu, Sep 10)
    Room C
    12:10-13:10 KOR

    Luncheon Session 3

    will be updated.
  • Day 1 (Thu, Sep 10)
    Room C
    13:10-14:30 KOR

    디지털헬스연구회 세션

    Eung Ju Kim (Korea Univ., Korea)
    Seonghoon Choi (Hallym Univ., Korea)

    인공지능과 디지털 헬스 기술이 심부전 진료와 심혈관 영상 분야에 어떻게 적용되고 있는지 이해한다.
    의료인을 위한 AI의 기본 개념부터 심부전 진료, 심혈관 영상, 심초음파 분야의 실제 활용 사례를 살펴보고 향후 발전 방향을 조망하고자 한다.
    13:10-13:25 의료인을 위한 AI, digital health의 이해 Sang-Ho Jo (Hallym Univ., Korea)
    13:25-13:40 심전도 AI의 heart failure관점에서 다양한 활용 Youngjin Cho (Seoul National Univ., Korea)
    13:40-13:55 심장혈관 영상에서 AI의 적용 Donghyun Yang (Ulsan Univ., Korea)
    13:55-14:10 AI-enhanced echocardiography: current and future Jiesuck Park (Seoul National Univ., Korea)
    14:10-14:30 Discussion Wonse Kim (Seoul National Univ., Korea)
    Won Kim (Novartis Korea, Korea)
    Sung Kee Ryu (Ewha Womans Univ., Korea)
    Minjae Yoon (Seoul National Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room C
    14:50-16:10 KOR

    [중증심부전 연구회] Smart management for heart transplant

    Seok Min Kang (Yonsei Univ., Korea)
    Jin Oh Choi (Sungkyunkwan Univ., Korea)

    진행성 심부전 환자의 최신 치료 전략과 중증심부전 관리의 핵심 이슈를 이해한다.
    최신 치료 전략과 실제 임상 경험을 공유하고, 중증심부전 환자의 예후 개선을 위한 실질적인 접근 방법을 정리한다.
    14:50-15:05 How to select best donor, My practical tip Sang Eun Lee (Ulsan Univ., Korea)
    15:05-15:20 Smart transplant allocation, Can AI help? Hyun-Jai Cho (Seoul National Univ., Korea)
    15:20-15:35 How to adjust immunosuppressants, My practical tip TBD
    15:35-15:50 Smart immunosuppressive treatment Jaewon Oh (Yonsei Univ., Korea)
    15:50-16:10 Discussion TBD
    Soo Yong Lee (Pusan National Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room C
    16:10-17:40 KOR

    [Ethics Session] 심부전 윤리 사례집 개발: 임상과 연구에서의 실제 사례 (Clinical and Research Ethics in Heart Failure)

    Jin-Ok Jeong (Chungnam National Univ., Korea)
    Kyung-Kuk Hwang (Chungbuk National Univ., Korea)

    심부전 진료 및 연구 과정에서 발생하는 주요 윤리적 쟁점을 이해한다.
    본 세션에서는 실제 사례를 바탕으로 임상윤리와 연구윤리의 주요 쟁점을 검토하고, 환자와 연구대상자 보호를 위한 원칙을 재확인한다.
    16:10-16:28 Research Ethics (연구 윤리) Sanghoon Na (Seoul National Univ., Korea)
    16:28-16:46 Clinical Ethics (말기심부전 환자의 생명 윤리) Dae Hwan Bae (Bucheon Sejong Hospital, Korea)
    16:46-17:04 환자의 선택과 의료진의 역할 - 심장이식을 거부한 환자의 윤리적 고찰 (Patient Choice and the Role of the Physician - Ethical Reflections on Heart Transplant Refusal) Mijoo Kim (Chungnam National Univ., Korea)
    17:04-17:22 학술발표 시 만나는 윤리적 순간들: AI나 타인의 자료를 이용할 때 Sang Min Park (Eulji Univ., Korea)
    17:22-17:40 Discussion Jangyoung kim (Yonsei Wonju Univ., Korea)
    Seon-Ah Jin (Chungnam National Univ., Korea)
    Uram Jin (Ajou Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room D
    13:30-14:40 KOR

    Debate 1: Fulminant Myocarditis: Steroids or Not?—Case-Based Debate Across Histotype

    Eun Seok Jeon (DaeHang Hospital, Korea)

    13:10-13:25 Case Vignette Heayoung Shin (Sungkyunkwan Univ., Korea)
    13:25-13:40 Early Corticosteroids in Fulminant Myocarditis: Why Time Matters Jeong Hoon Yang (Sungkyunkwan Univ., Korea)
    13:40-13:55 Fulminant Does Not Equal Immune-Mediated: Why We Should Be Cautious Minju Han (Seoul National Univ., Korea)
  • Day 1 (Thu, Sep 10)
    Room D
    16:10-17:40 KOR

    진료지침위원회 공청회

    Byung Su Yoo (Yonsei Wonju Univ., Korea)
    Sang Eun Lee (Ulsan Univ., Korea)

    16:10-16:20 KQ 1. HFimpEF에서 GDMT 감량(de-escalation) vs 유지 Ah-Ram Kim (Ulsan Univ., Korea)
    16:20-16:30 KQ 2. 비만 동반 HFpEF/HFmrEF에서 GLP-1 작용제(세마글루타이드)의 효과 Minjung Park (Seoul National Univ., Korea)
    16:30-16:40 KQ 3. HFpEF/HFmrEF에서 SGLT2 억제제의 효과 Jino Park (Inje Univ., Korea)
    16:40-16:50 KQ 4. HFpEF/HFmrEF에서 ARNI(사쿠비트릴/발사르탄)의 효과 Jae Yeong Cho (Chonnam National Univ., Korea)
    16:50-17:00 KQ 6. ATTR-CM에서 RNAi 치료(Vutrisiran)의 1차 치료 가치 TBD
    17:00-17:10 KQ 7. 급성 심부전(AHF) 입원 환자에서 SGLT2 억제제의 조기 시작의 효과 TBD
    17:10-17:20 KQ 8. 급성 심부전(AHF) 입원 환자에서 ARNI(엔트레스토)의 조기 시작의 효과 TBD
    17:20-17:30 KQ 5. HFpEF/HFmrEF에서 비스테로이드성 MRA(Finerenone)의 효과 Chan Joo Lee (Yonsei Univ., Korea)
    17:30-17:40 Discussion TBD
    Ran Heo (Hanyang Univ., Korea)
  • Day 1 (Thu, Sep 10)
    AGORA
    10:00-11:20 KOR

    HF Boot Camp 1: Mechanical Support, VAD

    10:00-10:10 Basics of LVAD: Candidate Selection and Long-Term Outcomes Junho Hyun (Ulsan Univ., Korea)
    10:10-10:20 ECLS in LVAD: From CS to post-LVAD RVF Soo Yong Lee (Pusan National Univ., Korea)
    10:20-10:30 Q&A Ah-Ram Kim (Ulsan Univ., Korea)
    Yoonjee Park (Bucheon Sejong Hospital, Korea)
    Jooyeon Lee (Yonsei Univ., Korea)
    David Hong (Sungkyunkwan Univ., Korea)
    10:45-10:50 (Mini-lecture 1) Assessment of the LVAD candidate Yoonjee Park (Bucheon Sejong Hospital, Korea)
    10:50-10:55 (Mini-lecture 2) Basic Hemodynamic and Parameters Jooyeon Lee (Yonsei Univ., Korea)
    10:55-11:00 (Mini-lecture 3) Echocardiographic and Hemodynamic Assessment after LVAD David Hong (Sungkyunkwan Univ., Korea)
    11:00-11:05 (Mini-lecture 4) Managing Critically Ill Candidates for LVAD Ah-Ram Kim (Ulsan Univ., Korea)
    11:05-11:20 Discussion Heayoung Shin (Sungkyunkwan Univ., Korea)
    Yongwhan Lim (Chonnam National Univ., Korea)
    Kina Jeon (The Catholic Univ. of Korea, Korea)
  • Day 1 (Thu, Sep 10)
    AGORA
    13:10-14:30 ENG

    13:30-14:40

    Moderated Poster 1

    TBD

    will be updated.
  • Day 1 (Thu, Sep 10)
    AGORA
    16:40-17:40 KOR

    16:40-17:40

    HF Boot Camp 2: Strategic Approaches to Research Publication

    Jin Joo Park (Seoul National Univ., Korea)
    TBD

    16:40-16:55 심부전 임상시험에서의 Win Ratio 이해: 결과 해석부터 임상시험 설계까지 (Win Ratio in Heart Failure Trials Made Simple: From Result Interpretation to Trial Design) Danbee Kang (Sungkyunkwan Univ., Korea)
    16:55-17:10 IJHF Editor-in-Chief가 전하는 논문 Accept 비법 Jin Joo Park (Seoul National Univ., Korea)
    17:10-17:25 AI를 활용한 연구 Figure 제작: 논문·슬라이드용 그림을 빠르고 세련되게 만드는 방법 (AI-Assisted Research Figure Design: Creating Publication-and Presentation-Ready Visuals) Dong Su Jang (MID, Korea)
    17:25-17:40 Discussion SungA Bae (Yonsei Univ., Korea)
    Taeil Yang (Gachon Univ., Korea)
    Ha Young Yu (Korea Univ., Korea)
    Ji Hyun Cha (Sungkyunkwan Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room A
    08:00-09:00 KOR

    Morning Session 1 Morning Session 1 logo

    will be updated.
  • Day 2 (Fri, Sep 11)
    Room A
    09:00-10:20 KOR

    Heart Failure Masterclass: The Day 2 Essentials [초심자를 위한 심부전 치료의 실제]

    Eung Ju Kim (Korea Univ., Korea)
    Seonghoon Choi (Hallym Univ., Korea)

    심부전 치료의 핵심 약제를 임상에서 실질적으로 적용하는 방법을 이해하고, 동반 질환인 심방세동의 관리 전략을 습득한다.
    심부전 약제의 실제 적용 순서와 용량 조절, 그리고 심방세동 병존 시 치료 전략은 임상에서 끊임없이 제기되는 과제이다. 본 세션은 심부전 약물치료의 실전 팁과 최신 변화를 초심자와 전문가 모두의 눈높이에서 체계적으로 정리하고자 한다.
    09:00-09:15 Practical Use of Diuretics, MRA, SGLT2 inhibitors in Heart Failure [이뇨제, MRA, SGLT2 억제제 실제 사용 TIP] Ju-Hee Lee (Chungbuk National Univ., Korea)
    09:15-09:30 Practical Use of ARNI and beta-blockers in Heart Failure [ARNI와 베타차단제 실제 사용 TIP] Seonhwa Lee (Yonsei Univ., Korea)
    09:30-09:45 Modern Drug Therapy for Heart Failure: Beyond 4 Pillar Drugs [4 Pillar 약제 이외 약제의 사용실제와 효과] Ji-Hun Jang (Inha Univ., Korea)
    09:45-10:00 Treatment Approaches for AF in Patients with HF [심부전 환자의 심방세동 치료와 변화] Jaemin Shim (Korea Univ., Korea)
    10:00-10:20 Discussion Ah-Ram Kim (Ulsan Univ., Korea)
    Se Eun Kim (Yonsei Wonju Univ., Korea)
    Jin-Jin Kim (The Catholic Univ. of Korea, Korea)
    SungA Bae (Yonsei Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room A
    10:50-12:10 KOR

    Joint Session with KSE

    What's Hot in Echocardiography in Heart Failure Practice?

    Goo Yeong Cho (Seoul National Univ., Korea)
    Seongwoo Han (Hallym Univ., Korea)

    심부전 진료에서 심초음파의 최신 가이드라인 적용과 AI 기반 진단 기술의 임상적 활용을 이해한다.
    이완기능 진단 가이드라인 업데이트, 기능성 승모판 역류의 감별, 인공지능 기반 자동 분석 등 심초음파 분야는 빠르게 진화하고 있다. 본 세션은 대한심장초음파학회(KSE)와 함께 심부전 진료에서 심초음파의 최신 적용 방법과 임상적 의미를 논의하고자 한다.
    10:50-11:05 2025 Updated Guideline for Diagnosis of Diastolic Function and HFpEF: Hyemoon Chung (Kyunghee Univ., Korea)
    11:05-11:20 Ventricular vs Atrial Functional MR: Diagnosis and Treatment Dae Hee Kim (Ulsan Univ., Korea)
    11:20-11:35 AI in Echocardiography for Diagnosis of Heart Failure Yeonyee Yoon (Seoul National Univ., Korea)
    11:35-11:50 Exercise Echocardiography in Heart Failure Eui-Young Choi (Yonsei Univ., Korea)
    11:50-12:10 Discussion Dae Hwan Bae (Bucheon Sejong Hospital, Korea)
    Jin Kyung Oh (Chungnam National Univ., Korea)
    Seonhwa Lee (Yonsei Univ., Korea)
    David Hong (Sungkyunkwan Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room A
    12:10-13:10 KOR

    Luncheon Session 4 Luncheon Session 4 logo

    will be updated.
  • Day 2 (Fri, Sep 11)
    Room A
    13:10-14:30 ENG

    Young Investigator Award

    TBD

    13:10-13:25 TBD TBD
    13:10-14:30 TBD TBD
    13:25-13:40 TBD TBD
    13:40-13:55 TBD TBD
    13:55-14:10 TBD TBD
    14:10-14:30 TBD TBD
  • Day 2 (Fri, Sep 11)
    Room A
    14:30-15:50 KOR/ENG

    Cardiac Amyloidosis 2026: Expanding Therapeutic Frontiers and Unresolved Controversies

    Eun Seok Jeon (DaeHang Hospital, Korea)
    Mi Seung Shin (Gachon Univ., Korea)

    To understand early diagnostic strategies and optimal treatment selection, including tafamidis, in cardiac amyloidosis.
    Once considered rare, cardiac amyloidosis is now increasingly recognized in clinical practice. With treatment timing, mono- vs. combination therapy, and redefining success beyond survival all rapidly evolving, this session aims to discuss the cutting edge of ATTR-CM management with international experts.
    14:30-14:50 The Importance of Timing: Early Tafamidis Therapy for Sustained Disease Modification Omar Siddiqi (Boston Univ. School of Medicine, USA)
    14:50-15:10 Emerging ATTR-CM Therapies: What is New? Jong Chan Youn (The Catholic Univ. of Korea, Korea)
    15:10-15:30 Redefining Treatment Success in ATTR-CM: Beyond Survival Darae Kim (Sungkyunkwan Univ., Korea)
    15:30-15:50 Discussion Hyung Yoon Kim (Incheon Sejong Hospital, Korea)
    Inki Moon (Soonchunhyang Univ., Korea)
    Moon-Seung Soh (Ajou Univ., Korea)
    So-Young Lee (The Catholic Univ. of Korea, Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    09:00-10:20 ENG

    Beyond Survival: Managing Heart Failure in the Era of Modern Cancer Therapy

    Il Suk Sohn (Kyung Hee Univ., Korea)
    Woo-Baek Chung (The Catholic Univ. of Korea, Korea)

    To review contemporary approaches to cardiovascular risk assessment and heart failure management in patients receiving modern cancer therapies.
    As cancer survival rates improve, therapy-induced cardiotoxicity has become a major determinant of long-term patient outcomes. This session dives into the evolving field of cardio-oncology, discussing the practical application of risk-stratification tools, recent clinical trial evidence, and proactive monitoring strategies like permissive cardiotoxicity.
    09:00-09:15 From Data to Decisions: What Cardio‑Oncology Factsheets Teach Us Seonhwa Lee (Yonsei Univ., Korea)
    09:15-09:30 HFA-ICOS Risk Score: A Practical Bridge Between Oncology and Cardiology Darae Kim (Sungkyunkwan Univ., Korea)
    09:30-09:45 Lessons from the Latest Cardio-oncology RCTs: Shaping the Future of HF Care Hyukjin Park (Chonnam National Univ., Korea)
    09:45-10:00 Permissive Cardiotoxicity and Intensive Monitoring: A New Paradigm in Cardio-oncology Novi Yanti Sari (Siloam Hospitals Lippo Village, Indonesia)
    10:00-10:20 Discussion Hee Jun Kim (Chung-Ang Univ., Oncology, Korea)
    Hyun Ju Yoon (Chonnam National Univ., Korea)
    Jung Sun Cho (The Catholic Univ. of Korea, Korea)
    Jah Yeon Choi (Korea Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    10:50-12:10 ENG

    Joint Session with ESC-HFA

    Shaping the Future of Personalized HF Care

    Byung Su Yoo (Yonsei Wonju Univ., Korea)
    Wilfried Mullens (Ziekenhuis Oost Limburg, Genk and Univ. Hasselt, Belgium)

    To explore personalized approaches to heart failure management integrating phenotype-based therapy, device optimization, and artificial intelligence.
    Partnering with the ESC-HFA, this session highlights future-oriented approaches redefining personalized heart failure care over the coming decade. The discussions will focus on leveraging artificial intelligence, advanced biomarker integration, and precision device therapies (such as CRT-D) to tailor management to individual disease trajectories.
    10:50-11:10 Towards Personalized GDMT in Heart Failure: Rethinking Phenotype-Based Therapy Gianluigi Savarese (Karolinska Institutet and South Hospital, Sweden)
    11:10-11:30 Towards Personalized Device Therapy in Heart Failure: Rethinking CRT-D Wilfried Mullens (Ziekenhuis Oost Limburg, Genk and Univ. Hasselt, Belgium)
    11:30-11:50 Towards Personalized Therapy: Integrating Human and Artificial Intelligence In-Cheol Kim (Keimyung Univ., Korea)
    11:50-12:10 Discussion Min-Seok Kim (Ulsan Univ., Korea)
    Minjae Yoon (Seoul National Univ., Korea)
    Sunki Lee (Korea Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    12:10-13:10 ENG

    Luncheon Session 5 Luncheon Session 5 logo

    will be updated.
  • Day 2 (Fri, Sep 11)
    Room B
    13:10-14:30 ENG

    Mechanisms of Heart Failure: From Basic Science to Clinical Insight

    Byung Hee Oh (Incheon Sejong Hospital, Korea)
    Kenneth Margulies (Univ. of Pennsylvania, USA)

    To understand the molecular, genetic, and translational mechanisms underlying heart failure and their clinical implications.
    Heart failure remains a biologically complex syndrome driven by diverse molecular pathways. This session bridges basic science and clinical practice, translating recent discoveries in genetics, epigenetics, and cardiovascular science into actionable insights that can ultimately improve bedside patient care.
    13:10-13:40 [Presidential Lecture From HFSA] Molecular Mechanisms of Heart Failure: From Bench to Bedside Kenneth Margulies (Univ. of Pennsylvania, USA)
    13:40-13:55 Genetic and Epigenetic Insights into Heart Failure Jaewon Oh (Yonsei Univ., Korea)
    13:55-14:10 Translational Advances in Heart Failure: Bridging Novel Mechanisms and Patient Care Hyun-Jai Cho (Seoul National Univ., Korea)
    14:10-14:30 Discussion So Ree Kim (Korea Univ., Korea)
    Jun-Bean Park (Seoul National Univ., Korea)
    Hyewon Lee (Pusan National Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    14:30-15:50 ENG

    Beyond Human Touch: Remote Monitoring & Protocolized Care Pathways in HF Clinics

    Dong Ju Choi (Seoul National Univ., Korea)
    Liviu Klein (Univ. of California San Francisco, USA)

    To review contemporary remote monitoring strategies and protocolized care pathways for improving outcomes in heart failure clinics.
    Modern heart failure management is extending beyond traditional outpatient clinics through digitally integrated care systems. This session explores how implantable diagnostics, EMR-integrated workflows, and structured remote monitoring pathways enable earlier detection of clinical deterioration while maintaining meaningful clinical decision-making.
    14:30-15:00 Remote Monitoring That Changes Outcomes: What to Measure, When to Act Liviu Klein (Univ. of California San Francisco, USA)
    15:00-15:15 From Reactive to Proactive: the Evolving Role of Implantable Diagnostics in HF Yongsoo Baek (Inha Univ., Korea)
    15:15-15:30 EMR-Integrated Remote Monitoring Workflows in HF Clinics Sunki Lee (Korea Univ., Korea)
    15:30-15:50 Discussion Min Gyu Kong (Bucheon Sejong Hospital, Korea)
    Yoonjee Park (Bucheon Sejong Hospital, Korea)
    Kyeong-Hyeon Chun (Yonsei Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room B
    16:10-17:10 ENG

    Presidential Lecture

    TBD

    16:20-16:45 Heart Failure in Japan: The Role of the Japanese Heart Failure Society Koichiro Kinugawa (Univ. of Toyama, Japan)
    16:45-17:10 Heart Failure 2026: From Guidelines to Precision, Prevention and Advocacy Wilfried Mullens (Ziekenhuis Oost Limburg, Genk and Univ. Hasselt, Belgium)
    17:10-17:20 Discussion TBD
  • Day 2 (Fri, Sep 11)
    Room B
    17:10-17:50 KOR

    Lifetime Achievement Award

    Byung Su Yoo (Yonsei Wonju Univ., Korea)
    TBD

    17:10-17:15 Introduction of Lifetime Achievement Award Wook-Jin Chung (Gachon Univ., Korea)
    17:15-17:45 Life-time Achievement Lecture Sukkeun Hong (Bucheon Sejong Hospital, Korea)
    17:45-17:50 Congratulatory Remarks Byung Su Yoo (Yonsei Wonju Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    09:00-10:20 KOR

    Joint Session with KSPH

    Pulmonary Hypertension in Practice

    Wook-Jin Chung (Gachon Univ., Korea)
    Kye Hun Kim (Chonnam National Univ., Korea)

    폐고혈압의 진단과 치료 전략을 실제 임상 관점에서 익힌다.
    폐고혈압은 심부전 환자에서 흔히 동반되지만 진단과 치료가 쉽지 않은 영역이다. 본 세션에서는 우심도자술과 영상검사의 실제 적용부터 최신 치료 근거까지 살펴보며, 실제 진료 현장에서 마주하는 다양한 상황에 대한 해결 방안을 함께 논의하고자 한다.
    09:00-09:15 When to Suspect Pre-Capillary or Combined PH in HF: Clinical Clues and My Experience Jung Hyun Choi (Pusan National Univ., Korea)
    09:15-09:30 Right Test, Right Time: Selecting Imaging Modalities and Key Diagnostic Clues Dae Hee Kim (Ulsan Univ., Korea)
    09:30-09:45 PAH-Targeted Therapy in PH due to Left Heart Disease: Current Evidence and Future Directions Taeil Yang (Gachon Univ., Korea)
    09:45-10:00 From Pulmonary Angiography to Balloon Pulmonary Angioplasty: Practical Insights from Clinical Experience Cheol Min Ahn (Yonsei Univ., Korea)
    10:00-10:20 Discussion Gi Beom Kim (Seoul National Univ., Korea)
    Sanghyun Lee (Pusan National Univ., Korea)
    Kyung Eun Ha (Gachon Univ., Korea)
    Ran Heo (Hanyang Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    10:50-12:10 KOR

    From HFrEF to HFimpEF: Treat, Taper, or Maintain?

    YS Byun (Inje Univ., Korea)
    Sang-Ho Jo (Hallym Univ., Korea)

    HFimpEF 환자에서 최적의 약물 유지 및 감량 전략을 이해한다.
    치료 후 심기능이 회복된 HFimpEF 환자는 점차 증가하고 있지만, 치료를 언제까지 유지해야 하는지는 여전히 중요한 논쟁거리이다. 이 세션에서는 약제별 근거를 바탕으로 치료 지속, 감량, 중단에 대한 최신 지견을 정리하고 실제 임상 의사결정에 도움을 주고자 한다.
    10:50-11:05 LV Recovery in HFrEF: Predictors, Therapeutic Drivers, and Prognostic Implications Jooyeon Lee (Yonsei Univ., Korea)
    11:05-11:20 Recovered EF After Ischemic Injury: Should Post-MI Beta-Blockers Be Continued? Jino Park (Inje Univ., Korea)
    11:20-11:35 Etiology-Driven Decisions in HFimpEF: Why Treat Forever? Nuri Lee (Chonnam National Univ., Korea)
    11:35-11:50 Not All Drugs Are Equal: Class-Specific Evidence for De-escalation in HFimpEF Junho Hyun (Ulsan Univ., Korea)
    11:50-12:10 Discussion Moojun Kim (NHIS Ilsan Hospital, Korea)
    Jin-Jin Kim (The Catholic Univ. of Korea, Korea)
    Sang Gon Yoon (Pusan National Univ., Korea)
    Kyugn Hee Lim (Dong-a Univ., Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    12:10-13:10 KOR

    Luncheon Session 6 Luncheon Session 6 logo

    will be updated.
  • Day 2 (Fri, Sep 11)
    Room C
    13:10-14:30 KOR

    Joint Session with NIH

    Collaborative Research, Practical Tips and Know-How

    Jae-Hwan Nam (National Institute of Health, Korea)
    Byung Su Yoo (Yonsei Wonju Univ., Korea)

    심부전 연구에 활용 가능한 국가 연구 인프라와 다학제 연구 방법론을 이해한다.
    심부전 연구는 점차 대규모 데이터와 다학제 협력을 기반으로 발전하고 있다. 본 세션에서는 NIH 연구자원, 국가 코호트, 연구 플랫폼 활용법을 소개하고 실제 연구 수행 경험을 공유하여 연구 역량 향상에 도움을 주고자 한다.
    13:10-13:22 From Clinic to Grant: 임상의사를 위한 NIH 연구과제 길라잡이 Sang Cheol Kim (National Institute of Health, Korea)
    13:22-13:34 심부전 연구에 활용할 수 있는 NIH 코호트: 심혈관 코호트를 넘어, 만성질환·일반인 코호트까지 Hyun Joung Lim (National Institute of Health, Korea)
    13:34-13:46 세계 각국은 심부전 연구에 어떻게 투자하는가: 국가 코호트와 국책 연구 프로그램의 해외 동향 Jong Chan Youn (The Catholic Univ. of Korea, Korea)
    13:46-13:58 NIH 연구자원을 활용한 연구 사례 TBD
    13:58-14:10 From Bedside to Genome: NIH 인프라를 활용한 심부전 유전체 협력 연구의 실제 Sang Eun Lee (Ulsan Univ., Korea)
    14:10-14:30 Discussion Bong Jo Kim (National Institute of Health, Korea)
    In-Cheol Kim (Keimyung Univ., Korea)
    Won-Ho Kim (National Institute of Health, Korea)
    Ju-Hee Lee (Chungbuk National Univ., Korea)
    Jae Pil Jeon (National Institute of Health, Korea)
  • Day 2 (Fri, Sep 11)
    Room C
    14:30-15:50 KOR

    Multidisciplinary Out-of-hospital Approaches: Reframing HF Care

    Hyun Joo Kim (Yonsei Univ., Korea)
    Sung Hea Kim (Konkuk Univ., Korea)

    병원 밖에서 이루어지는 다학제 심부전 관리의 중요성과 실제 적용 방안을 이해한다.
    심부전 치료의 성패는 입원 중 치료뿐 아니라 퇴원 이후의 지속적인 관리에 달려 있다. 본 세션에서는 지역사회 연계, 다학제 협력, 운동 및 영양 관리 등 병원 밖에서 실현 가능한 다양한 관리 모델을 소개하며 새로운 심부전 진료 패러다임을 제시하고자 한다.
    14:30-14:45 Transitional Care Models for HF Patients: A Multidisciplinary Team Approach TBD
    14:45-15:00 Sustainable HF Care through Community Networking Myung Ju Seo (Bucheon Sejong Hospital, Korea)
    15:00-15:15 Redefining Exercise in HF: Beyond Aerobic Tradition Kyuwan Lee (Ewha Womans Univ., Kinesiology, Korea)
    15:15-15:30 From Sodium Restriction to Muscle Nutrition: A New Dietary Perspective in HF TBD
    15:30-15:50 Discussion Yoonseon Kim (Ulsan Univ., Korea)
    Seunghyun Lee (Yonsei Univ., Korea)
    TBD
  • Day 2 (Fri, Sep 11)
    Room D
    09:00-10:20 KOR

    Meets the Industries 1 Meets the Industries 1 logo

    09:00-09:15 TBD TBD
    09:15-09:30 TBD TBD
    09:30-09:45 TBD TBD
    09:45-10:00 TBD TBD
    10:00-10:20 TBD TBD
  • Day 2 (Fri, Sep 11)
    Room D
    13:10-14:30 KOR

    중증심부전 환자 진료의 제도 보완

    Wook-Jin Chung (Gachon Univ., Korea)
    Hae Young Lee (Seoul National Univ., Korea)

    13:10-13:25 좌심실 보조장치 승인 절차 및 지속 관리 수가 개선 필요성 Soo Yong Lee (Pusan National Univ., Korea)
    13:25-13:40 좌심실 보조장치 / 심장 이식 인증제 도입의 필요성 Yang Hyun Cho (Sungkyunkwan Univ., Korea)
    13:40-14:00 중증심부전 환자 급여기준/관리수가에 대한 정부 정책 기조 TBD
    14:00-14:30 Discussion Young Hwan Park (HEALTH INSURANCE REVIEW & ASSESSMENT SERVICE, Korea)
    Sukmin Seo (The Catholic Univ., Korea)
    Jae Seung Jung (Korea Univ., Korea)
    Sukkeun Hong (Bucheon Sejong Hospital, Korea)
  • Day 2 (Fri, Sep 11)
    Room D
    14:30-15:50 KOR

    Debate 2: Transcatheter or Transplant

    Jin-Ok Jeong (Chungnam National Univ., Korea)

    14:30-14:45 TEER First: Bridge to Recovery or Bridge to Decision? Jiwon Seo (Yonsei Univ., Korea)
    14:45-15:00 LVAD/Transplant First: Don’t Miss the Window—Early Referral Saves Lives Soo Yong Lee (Pusan National Univ., Korea)
    15:00-15:30 Rebuttal Round Jiwon Seo (Yonsei Univ., Korea)
    Soo Yong Lee (Pusan National Univ., Korea)
    15:30-15:50 Open Dialogue and Audience Voting TBD
  • Day 2 (Fri, Sep 11)
    AGORA
    08:00-09:00 ENG

    Meet the Expert 1

    Koichiro Kinugawa (Univ. of Toyama, Japan)
    Liviu Klein (Univ. of California San Francisco, USA)
    Matthew Martinez (Mayo Clinic, USA)
    Yasuhiko Sakata (National Cerebral and Cardiovascular Center, Japan)

    will be updated.
  • Day 2 (Fri, Sep 11)
    AGORA
    09:00-10:50 ENG

    09:00-10:50

    HF Clinical Research Award

    will be updated.
  • Day 2 (Fri, Sep 11)
    AGORA
    10:20-10:50

    Vaccines and Heart Failure: An Overlooked Lifesaving Strategy

    will be updated.
  • Day 2 (Fri, Sep 11)
    AGORA
    13:10-14:30 ENG

    Moderated Poster 2

    TBD

    will be updated.
  • Day 2 (Fri, Sep 11)
    AGORA
    14:30-15:50 KOR

    기자간담회

    will be updated.
  • Day 3 (Sat, Sep 12)
    Room A
    08:50-10:10 KOR/ENG

    Hypertrophic Cardiomyopathy in 2026: From Risk Stratification to Targeted Therapy

    Eui-Young Choi (Yonsei Univ., Korea)
    Matthew Martinez (Mayo Clinic, USA)

    To understand risk stratification and apply the latest targeted treatments, including cardiac myosin inhibitors, in hypertrophic cardiomyopathy.
    HCM presents with heterogeneous phenotypes, making personalized risk stratification and treatment essential. With cardiac myosin inhibitors reshaping the therapeutic landscape, this session featuring Mayo Clinic experts aims to address the key clinical challenges in HCM management in 2026.
    08:50-09:05 The Silent Thick Heart: Risk Stratification and Surveillance in HCM Hyun-Jung Lee (Seoul National Univ., Korea)
    09:05-09:20 Genetic Testing in HCM: From Variant Detection to Clinical Decision-Making Jiwon Seo (Yonsei Univ., Korea)
    09:20-09:35 The New Era of HCM: Myosin Inhibitors and d Personalized Treatment Strategies Matthew Martinez (Mayo Clinic, USA)
    09:35-09:50 Beyond Hypertrophy: Recognizing and Managing End-Stage HCM In-Cheol Kim (Keimyung Univ., Korea)
    09:50-10:10 Discussion Seo-Yeon Gwak (Korea Univ., Korea)
    Min Sun Kim (Inje Univ., Korea)
    Jong-Ho Nam (Yeungnam Univ., Korea)
    Hee Jeong Lee (Keimyung Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room A
    10:30-11:50 KOR

    Joint Session with KHRS

    Managing Arrhythmia in Heart Failure: From Chaos to Order

    Seong-Mi Park (Korea Univ., Korea)
    Eue-Keun Choi (Seoul National Univ., Korea)

    심부전 환자에서 동반되는 다양한 부정맥의 최신 치료 전략과 중재적 접근법을 이해한다.
    본 세션은 심방세동, 심실성 부정맥 및 conduction abnormality에 대한 최신 치료 전략과 device/intervention 기반 접근법을 통해 심부전 환자의 예후 개선 방안을 논의하고자 한다.
    10:30-10:45 Arrhythmia Management and Clinical Outcomes: Perspective of a HF Specialist Junho Hyun (Ulsan Univ., Korea)
    10:45-11:00 Who Benefits Most? Pulsed Field Ablation for AF in HF Hyoung-Seob Park (Keimyung Univ., Korea)
    11:00-11:15 Physiologic Pacing in HF: is Left Bundle Branch Area Pacing a Game Changer? So Ryoung Lee (Seoul National Univ., Korea)
    11:15-11:30 Refractory Ventricular Tachycardia: From Catheter Ablation to Noninvasive Substrate Therapy Min Soo Cho (Ulsan Univ., Korea)
    11:30-11:50 Discussion Dae Young Kim (Inha Univ., Korea)
    Yun Gi Kim (Korea Univ., Korea)
    Jiwon Seo (Yonsei Univ., Korea)
    David Hong (Sungkyunkwan Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room A
    12:30-13:30 KOR

    Luncheon Session 7 Luncheon Session 7 logo

    will be updated.
  • Day 3 (Sat, Sep 12)
    Room A
    13:30-14:50 KOR

    [대외위원회 세션] First-line Evaluation of Acute Heart Failure Patients [급성 심부전 환자의 초기평가]

    Young Ae Kang (Ulsan Univ., Korea)
    Ju-Hee Lee (Chungbuk National Univ., Korea)

    급성 심부전 환자의 초기 평가를 위한 실질적이고 체계적인 접근법을 이해한다.
    본 세션에서는 급성 심부전 환자의 bedside assessment, 영상 및 혈역학적 평가, 유발 인자 확인 등 실제 임상에서 활용 가능한 초기 접근 전략을 논의하고자 한다.
    13:30-13:45 Bedside Hemodynamic Profiling in Acute HF: From Classification to Treatment [급성 심부전의 혈역학: Profile 분류와 이에 맞는 치료 전략 세우기] TBD
    13:45-14:00 Why Did the Patient Decompensate? Identifying the Triggers of Acute HF [왜 나빠졌을까? 급성 심부전 원인 찾기의 정석] DH Shin (Yonsei Univ., Korea)
    14:00-14:15 I/O Targets in Acute HF: Myths, Realities, and Clinical Pearls [I/O 타겟을 얼마로 할까요? I/O 잘 활용하는 비법] Ji-Hun Jang (Inha Univ., Korea)
    14:15-14:30 Genetics Behind HF: When to Suspect and How to Interpret [심부전 뒤에 숨은 유전자: 언제 의심하고 어떻게 해석할까] Uram Jin (Ajou Univ., Korea)
    14:30-14:50 Discussion Min Sun Kim (Inje Univ., Korea)
    Jisu Kim (Yonsei Univ., Korea)
    Sohyun Lee (Korea Univ., Korea)
    Soo Yong Lee (Pusan National Univ., Korea)
    Yunho Cho (Gyeongsang National Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room A
    15:10-16:30 KOR

    Cardio-Rheumatology Challenges: Managing Inflammation

    Sang-Ho Jo (Hallym Univ., Korea)
    Hae Young Lee (Seoul National Univ., Korea)

    염증 및 면역 반응이 심혈관질환과 심부전에 미치는 영향을 이해한다.
    염증과 면역 반응은 심혈관 질환과 심부전의 발생 및 진행에 중요한 역할을 한다. 본 세션은 cardio-rheumatology 영역에서 주목받고 있는 염증성 심근질환과 자가면역 연관 심부전에 대한 최신 지견과 치료 전략을 공유하고자 한다.
    15:10-15:25 Cardiovascular Manifestations of Systemic Autoimmune Diseases TBD
    15:25-15:40 Modern Diagnostics for Myocarditis and Inflammatory Cardiomyopathy So Ree Kim (Korea Univ., Korea)
    15:40-15:55 Cardiac Sarcoidosis: Inflammation, Arrhythmia, and Heart Failure Jae Yeong Cho (Chonnam National Univ., Korea)
    15:55-16:10 Immunosuppression in Myocarditis and Vasculitis TBD
    16:10-16:30 Discussion Mijoo Kim (Chungnam National Univ., Korea)
    Mi Hyun Kim (Catholic Kwandong Univ., Korea)
    Jeen Hwa Lee (Hallym Univ., Korea)
    Ran Heo (Hanyang Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    08:00-08:50 ENG

    Morning Session 2

    will be updated.
  • Day 3 (Sat, Sep 12)
    Room B
    08:50-10:10 ENG

    CKM Syndrome: New Insights, Emerging Therapies, and Unresolved Challenges

    Wook-Jin Chung (Gachon Univ., Korea)
    Gianluigi Savarese (Karolinska Institutet and South Hospital, Sweden)

    To provide an updated understanding of CKM syndrome and review emerging therapeutic strategies and unresolved clinical challenges across the cardiovascular–renal–metabolic continuum.
    The emerging concept of CKM syndrome reflects the deeply interconnected nature of cardiovascular, renal, and metabolic diseases. This session reviews contemporary epidemiology, congestion biology, and unresolved clinical questions—including the expanding role of obesity management and MRAs—to help clinicians navigate these overlapping disease domains.
    08:50-09:05 Heart Failure in CKM Syndrome: Insights from Epidemiology to Risk Stratification Jin Joo Park (Seoul National Univ., Korea)
    09:05-09:20 Redefining Obesity Treatment in Heart Failure Prevention: Targeting Metabolically Unhealthy Obesity Yasuhiko Sakata (National Cerebral and Cardiovascular Center, Japan)
    09:20-09:35 Congestion and Cardiorenal Interaction in Heart Failure Wilfried Mullens (Ziekenhuis Oost Limburg, Genk and Univ. Hasselt, Belgium)
    09:35-09:50 Who Should Receive MRAs in CKM Syndrome? Bridging the Gap Between Guidelines and Practice Javed Butler (Baylor Scott & White, USA)
    09:50-10:10 Discussion TBD
    Dae Hwan Bae (Bucheon Sejong Hospital, Korea)
    Kina Jeon (The Catholic Univ. of Korea, Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    10:30-11:50 ENG

    Joint Session with JHFS

    Decision-Making in Heart Failure: Navigating Uncertainty and Unmet Needs

    Koichiro Kinugawa (Univ. of Toyama, Japan)
    TBD

    To understand contemporary decision-making strategies in complex clinical situations of heart failure management.
    Despite major advances in HF therapy, many clinical situations still require individualized decision-making beyond guideline recommendations. This session will discuss practical approaches for managing uncertainty and unmet needs in HF care.
    10:30-10:45 BNP-based Heart Failure Care: A Japanese Model for Precision Medicine Koichiro Kuwahara (Shinshu Univ., Japan)
    10:45-11:00 Phenotyping-based Heart Failure Care: From Risk Stratification to Treatment Dong-Hyuk Cho (Korea Univ., Korea)
    11:00-11:15 Atrial Functional MR in Heart Failure: From Evidence to Practice Hiroshi Ueno (Univ. of Toyama, Japan)
    11:15-11:30 Functional TR in Heart Failure: From Evidence to Practice Chi Young Shim (Yonsei Univ., Korea)
    11:30-11:50 Discussion Sung Ji Park (Sungkyunkwan Univ., Korea)
    Nuri Lee (Chonnam National Univ., Korea)
    Hyemoon Chung (Kyunghee Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    12:30-13:30 ENG

    Luncheon Session 8 Luncheon Session 8 logo

    will be updated.
  • Day 3 (Sat, Sep 12)
    Room B
    13:30-14:50 ENG

    Tailoring Modern HF Therapy: Integrating Evidence-Based Evolution into Practice

    Seok Min Kang (Yonsei Univ., Korea)
    Koichiro Kinugawa (Univ. of Toyama, Japan)

    To understand how evolving evidence can be effectively integrated into contemporary heart failure management.
    Rapid advances in HF research continue to reshape clinical practice. This session will review recent evidence and discuss practical strategies for translating clinical trial findings into real-world HF care.
    13:30-13:50 SGLT2 Inhibitors in Heart Failure: Translating Evidence into Multi-Organ Benefits Javed Butler (Baylor Scott & White, USA)
    13:50-14:10 Big Data to Bedside: Harmonizing Registry Evidence with Randomized Clinical Trials Gianluigi Savarese (Karolinska Institutet and South Hospital, Sweden)
    14:10-14:30 The Evolution of Heart Failure: Leveraging Past Insights to Shape Future Progress Byung Su Yoo (Yonsei Wonju Univ., Korea)
    14:30-14:50 Discussion Kyung-Jin Kim (Ewha Womans Univ., Korea)
    Min-Seok Kim (Ulsan Univ., Korea)
    Jaewon Oh (Yonsei Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    15:10-16:30 ENG

    Hot Topics in HF: Navigating the EF Spectrum

    Seonghoon Choi (Hallym Univ., Korea)
    Jian Zhang (Fuwai hospital, China)

    To understand recent advances in heart failure management across the ejection fraction spectrum.
    HF encompasses diverse phenotypes according to left ventricular ejection fraction. This session will review emerging evidence and evolving therapeutic strategies for HFrEF, HFpEF, and HFimpEF.
    15:10-15:30 Top 3 Clinical Research in HFrEF (2025-2026) Novi Yanti Sari (Siloam Hospitals Lippo Village, Indonesia)
    15:30-15:50 Top 3 Clinical Research in HFpEF (2025-2026) Koichiro Kuwahara (Shinshu Univ., Japan)
    15:50-16:10 Top 3 Clinical Research in HFimpEF (2025-2026) Ji-Hun Jang (Inha Univ., Korea)
    16:10-16:30 Discussion Moojun Kim (NHIS Ilsan Hospital, Korea)
    Jooyeon Lee (Yonsei Univ., Korea)
    Kyung Eun Ha (Gachon Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room B
    16:30-16:30

    Lucky Draw and Closing Remark

    will be updated.
  • Day 3 (Sat, Sep 12)
    Room C
    08:50-10:10 KOR

    Ischemic Cardiomyopathy: Which Truly Saves the Heart?

    Kyung-Kuk Hwang (Chungbuk National Univ., Korea)
    TBD

    허혈성 심근병증 환자의 예후를 개선하는 핵심 치료 전략을 이해한다.
    허혈성 심근병증은 여전히 심부전의 주요 원인 중 하나이며 다양한 치료 선택지가 존재한다. 본 세션에서는 약물치료, 재관류치료, 기계적 순환보조장치 및 심장재활의 역할을 균형 있게 조명하여 실제 환자에게 가장 효과적인 치료 전략이 무엇인지 함께 고민해보고자 한다.
    08:50-09:05 GDMT Is Enough: Optimizing Ischemic CMP with Medical Therapy Yoonjee Park (Bucheon Sejong Hospital, Korea)
    09:05-09:20 Revascularization Is Essential: Changing Prognosis in Ischemic CMP Joo Myung Lee (Sungkyunkwan Univ., Korea)
    09:20-09:35 Mechanical Circulatory Support Is Necessary During High-Risk PCI in ischemic CMP Ji Hyun Cha (Sungkyunkwan Univ., Korea)
    09:35-09:50 Cardiac Rehabilitation Should Not Be Overlooked in Ischemic CMP Min Gyu Kong (Bucheon Sejong Hospital, Korea)
    09:50-10:10 Discussion Jin Wi (Gachon Univ., Korea)
    Soo Youn Lee (Incheon Sejong Hospital, Korea)
    Hyun-Su Ha (Yonsei Univ., Korea)
    TBD
  • Day 3 (Sat, Sep 12)
    Room C
    10:30-11:50 KOR

    [정밀의료 연구회] Human Cardiac Organoids and Engineered Platforms

    Myeong-Chan Cho (Chungbuk National Univ., Korea)
    Jin-Ok Jeong (Chungnam National Univ., Korea)

    인간 심장 오가노이드와 engineered platform 기반의 최신 중개연구 기법을 이해한다.
    심부전 연구는 patient-specific modeling과 advanced bioengineering 기술의 발전으로 새로운 전환점을 맞이하고 있다. 본 세션은 cardiac organoid와 engineered platform 기반 연구의 최신 동향과 임상 적용 가능성을 소개하고자 한다.
    10:30-10:50 Engineering the Human Heart in a Dish: Current State of Cardiac Organoids TBD
    10:50-11:10 The Janus Face of VUS: A Spectrum from Hot to Benign TBD
    11:10-11:30 Genome sequencing, short vs long read TBD
    11:30-11:50 Discussion Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
    Sang Eun Lee (Ulsan Univ., Korea)
    Wook-Jin Chung (Gachon Univ., Korea)
  • Day 3 (Sat, Sep 12)
    Room C
    12:30-13:30 KOR

    Luncheon Session 9 Luncheon Session 9 logo

    will be updated.
  • Day 3 (Sat, Sep 12)
    Room C
    13:30-14:50 KOR

    Advanced Heart Failure Therapies: Innovations in Mechanical Support and Transplantation

    Sung-Ho Jung (Ulsan Univ., Thoracic and Cardiovascular Surgery, Korea)
    Hyun-Jai Cho (Seoul National Univ., Korea)

    심부전 연구는 patient-specific modeling과 advanced bioengineering 기술의 발전으로 새로운 전환점을 맞이하고 있다. 본 세션은 cardiac organoid와 engineered platform 기반 연구의 최신 동향과 임상 적용 가능성을 소개하고자 한다.
    본 세션은 최신 device therapy, transplantation innovation 및 미래 치료 방향에 대해 논의하고자 한다.
    13:30-13:45 Next-Generation LVADs: Engineering Advances, Hemocompatibility, and the Vision for Fully Implantable Support Kyung-Hee Kim (Incheon Sejong Hospital, Korea)
    13:45-14:00 Smarter MCS with Predictive Monitoring, Adaptive Flow, and Precision Support Ah-Ram Kim (Ulsan Univ., Korea)
    14:00-14:15 Beyond the Ideal Donor: Expanding the Donor Pool through Advanced Preservation and DCD Strategies Kitae Kim (Ulsan Univ., Korea)
    14:15-14:30 Current Evidence, Remaining Barriers, and Future Directions of Cardiac Xenotransplantation Jong Chan Youn (The Catholic Univ. of Korea, Korea)
    14:30-14:50 Discussion In-Cheol Kim (Keimyung Univ., Korea)
    Min Ho Ju (Pusan National Univ., Thoracic and Cardiovascular Surgery, Korea)
  • Day 3 (Sat, Sep 12)
    Room C
    15:10-16:30 KOR

    Everyday Clinical Management of HF: Practical Guidance for Physicians

    Jin Oh Choi (Sungkyunkwan Univ., Korea)
    TBD

    실제 임상에서 흔히 접하는 심부전 관리 상황에 대한 practical approach를 이해한다.
    본 세션은 실제 진료에서 자주 마주하는 상황들을 중심으로 practical하고 적용 가능한 심부전 환자의 장기 관리 전략을 공유하고자 한다.
    15:10-15:30 Practical Evaluation of Dyspnea: Is it Heart Failure? [호흡곤란, 심부전 진단의 실전 포인트] Bong-Joon Kim (Kosin Univ., Korea)
    15:30-15:50 From Hospital to Clinic: Maintaining GDMT in Stable HF [대학병원에서 재의뢰된 안정된 심부전 환자, GDMT 유지법] Hyejung Choi (Hallym Univ., Korea)
    15:50-16:10 AF with RVR in HF Patients: Practical Approach to Acute and Ongoing Management [심부전 환자의 빠른 심방세동, 초동 대처와 만성 약물치료] Hee-Sun Mun (Yonsei Univ., Korea)
    16:10-16:30 Discussion Ji Eun Kwon (Kwon Ki-ik Internal Medicine Clinic, Korea)
    Sahng Lee (Smart Internal Medicine Clinic, Korea)
    Seong Choon Choe (OK Heart Internal Medicine Clinic, Korea)
    TBD
  • Day 3 (Sat, Sep 12)
    Room D
    08:50-10:10 KOR

    Meets the Industries 2 Meets the Industries 2 logo

    08:50-09:05 TBD TBD
    09:05-09:20 TBD TBD
    09:20-09:35 TBD TBD
    09:35-09:50 TBD TBD
    09:50-10:10 TBD TBD
  • Day 3 (Sat, Sep 12)
    Room D
    10:30-11:50 KOR

    Meets the Industries 3 Meets the Industries 3 logo

    10:30-10:45 TBD TBD
    10:45-11:00 TBD TBD
    11:00-11:15 TBD TBD
    11:15-11:30 TBD TBD
    11:30-11:50 TBD TBD
  • Day 3 (Sat, Sep 12)
    Room D
    13:30-14:50 KOR

    Debate 3: Weight Reduction in Heart Failure

    Hae Young Lee (Seoul National Univ., Korea)

    13:30-13:45 Weight reduction should be actively pursued as standard HF therapy Kangun Choi (Yeungnam Univ., Korea)
    13:45-14:00 Weight reduction is not universally beneficial; can be harmful in many HF patients Junho Hyun (Ulsan Univ., Korea)
    14:00-14:30 Rebuttal Round Kangun Choi (Yeungnam Univ., Korea)
    Junho Hyun (Ulsan Univ., Korea)
    14:30-14:50 Open Dialogue and Audience Voting TBD
  • Day 3 (Sat, Sep 12)
    AGORA
    08:00-08:50 ENG

    Meet the Expert 2

    Gianluigi Savarese (Karolinska Institutet and South Hospital, Sweden)
    Javed Butler (Baylor Scott & White, USA)
    Kenneth Margulies (Univ. of Pennsylvania, USA)
    Wilfried Mullens (Ziekenhuis Oost Limburg, Genk and Univ. Hasselt, Belgium)

    will be updated.
  • Day 3 (Sat, Sep 12)
    AGORA
    08:50-10:10 ENG

    Moderated Poster 3

    will be updated.
  • Day 3 (Sat, Sep 12)
    AGORA
    10:30-11:50 KOR

    HF Boot Camp 3: Mastering Sarcopenia and Rehabilitation in Heart Failure

    Daegyun Park (Hallym Univ., Korea)
    Eung Ju Kim (Korea Univ., Korea)

    10:30-10:40 Reframing Heart Failure Through the Lens of Sarcopenia Chan Joo Lee (Yonsei Univ., Korea)
    10:40-10:50 How to Prescribe Exercise in Heart Failure: Real-World Rehabilitation Protocols Byeong Ju Lee (Pusan National Univ., Korea)
    10:50-11:00 How to Read CPET: A Step-by-Step Clinical Guide Seung Hak Lee (Asan Medical Center, Korea)
    11:00-11:50 근심 (Muscle–Heart) Challenge: Try It Yourself!- CPEX 기계 두 대 - 참가자 두 명이 각각 뛰는 동안 실시간으로 CPET 결과 해석 및 질의응답 So Ree Kim (Korea Univ., Korea)
    Min Gyu Kong (Bucheon Sejong Hospital, Korea)
    Taeil Yang (Gachon Univ., Korea)
    Kangun Choi (Yeungnam Univ., Korea)
    TBD
  • Day 3 (Sat, Sep 12)
    AGORA
    13:30-14:50 KOR

    Heart Failure Seoul Meets Asia: Korea Training Reflections from Asia

    Wook-Jin Chung (Gachon Univ., Korea)
    TBD

    13:30-13:40 Heart Failure Management in Indonesia TBD
    13:40-13:50 Enhancing Heart Failure Care in Vietnam TBD
    13:50-14:00 Connecting Care Models: Philippine Perspectives TBD
    14:00-14:10 Building HF Infrastructure in Mongolia TBD
    14:10-14:20 From Korea Training to Local Practice: Cambodian Reflections TBD
    14:20-14:50 Discussion TBD
  • Day 3 (Sat, Sep 12)
    AGORA
    15:00-16:20 KOR

    15:00-16:20

    Life Beyond HF clinic

    Jae-Hyeong Park (Chungnam National Univ., Korea)
    Jung Hyun Choi (Pusan National Univ., Korea)

    15:00-15:20 비싸지 않아도 괜찮아: 쉽고 즐거운 와인 생활 Jino Park (Inje Univ., Korea)
    15:20-15:40 모터스포츠, 생각보다 가까이 있어요: | 국내에서 즐기는 모터스포츠 입문 Nuri Lee (Chonnam National Univ., Korea)
    15:40-16:00 잠깐 떠나도 괜찮아: 나를 회복하는 여행 Minsoo Kim (Asan Heart Internal Medicine Clinic, Korea)
    16:00-16:20 Discussion Seo-Yeon Gwak (Korea Univ., Korea)
    Hyukjin Park (Chonnam National Univ., Korea)
    Ji Eun Lee (Korea Univ., Korea)
    Kyeong-Hyeon Chun (Yonsei Univ., Korea)
    Junho Hyun (Ulsan Univ., Korea)